Literature DB >> 17625041

Effect of overexpression of PPARgamma on the healing process of corneal alkali burn in mice.

Shizuya Saika1, Osamu Yamanaka, Yuka Okada, Takeshi Miyamoto, Ai Kitano, Kathleen C Flanders, Yoshitaka Ohnishi, Yuji Nakajima, Winston W-Y Kao, Kazuo Ikeda.   

Abstract

Wound healing involves both local cells and inflammatory cells. Alkali burn of ocular surface tissue is a serious clinical problem often leading to permanent visual impairment resulting from ulceration, scarring and neovascularization during healing. Behaviors of corneal cells and inflammatory cells are orchestrated by growth factor signaling networks that have not been fully uncovered. Here we showed that adenoviral gene introduction of peroxisome proliferator-activated receptor-gamma (PPARgamma) inhibits activation of ocular fibroblasts and macrophages in vitro and also induced anti-inflammatory and anti-fibrogenic responses in an alkali-burned mouse cornea. PPARgamma overexpression suppressed upregulation of inflammation/scarring-related growth factors and matrix metalloproteinases (MMPs) in macrophages. It also suppressed expression of such growth factors and collagen Ialpha2 and myofibroblast generation upon exposure to TGFbeta1. Exogenous PPARgamma did not alter phosphorylation of Smad2, but inhibited its nuclear translocation. PPARgamma overexpression enhanced proliferation of corneal epithelial cells, but not of fibroblasts in vitro. Epithelial cell expression of MMP-2/-9 and TGFbeta1 and its migration were suppressed by PPARgamma overexpression. In vivo experiments showed that PPARgamma gene introduction suppressed monocytes/macrophages invasion and suppressed the generation of myofibroblasts, as well as upregulation of cytokines/growth factors and MMPs in a healing cornea. In vivo re-epitheliazation with basement membrane reconstruction in the healing, burned, cornea was accelerated by PPARgamma-Ad expression, although PPARgamma overexpression was considered to be unfavorable for cell migration. Together, these data suggest that overexpression of PPARgamma may represent an effective new strategy for treatment of ocular surface burns.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17625041     DOI: 10.1152/ajpcell.00332.2006

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  33 in total

1.  Dependence of resolvin-induced increases in corneal epithelial cell migration on EGF receptor transactivation.

Authors:  Fan Zhang; Hua Yang; Zan Pan; Zheng Wang; J Mario Wolosin; Per Gjorstrup; Peter S Reinach
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-10       Impact factor: 4.799

2.  [Chemical and thermal eye burns. Conservatíve and surgical options of a stage-dependent therapy].

Authors:  H G Struck; N F Schrage
Journal:  Ophthalmologe       Date:  2011-10       Impact factor: 1.059

Review 3.  Gene therapy in the cornea: 2005--present.

Authors:  Rajiv R Mohan; Jonathan C K Tovey; Ajay Sharma; Ashish Tandon
Journal:  Prog Retin Eye Res       Date:  2011-09-28       Impact factor: 21.198

4.  Epidermal growth factor receptor transactivation by the cannabinoid receptor (CB1) and transient receptor potential vanilloid 1 (TRPV1) induces differential responses in corneal epithelial cells.

Authors:  H Yang; Z Wang; J E Capó-Aponte; F Zhang; Z Pan; P S Reinach
Journal:  Exp Eye Res       Date:  2010-07-07       Impact factor: 3.467

5.  TRPA1 is required for TGF-β signaling and its loss blocks inflammatory fibrosis in mouse corneal stroma.

Authors:  Yuka Okada; Kumi Shirai; Peter S Reinach; Ai Kitano-Izutani; Masayasu Miyajima; Kathleen C Flanders; James V Jester; Makoto Tominaga; Shizuya Saika
Journal:  Lab Invest       Date:  2014-07-28       Impact factor: 5.662

6.  The influence of various toxic effects on the cornea and changes in corneal light transmission.

Authors:  Cestmír Cejka; Taras Ardan; Jakub Sirc; Jiří Michálek; Blanka Brůnová; Jitka Cejková
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-07-02       Impact factor: 3.117

7.  Effects of PPAR gamma ligands on TGF-beta1-induced epithelial-mesenchymal transition in alveolar epithelial cells.

Authors:  Xiahui Tan; Hayat Dagher; Craig A Hutton; Jane E Bourke
Journal:  Respir Res       Date:  2010-02-23

8.  Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.

Authors:  P J Simpson-Haidaris; S J Pollock; S Ramon; N Guo; C F Woeller; S E Feldon; R P Phipps
Journal:  PPAR Res       Date:  2010-02-28       Impact factor: 4.964

9.  PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis.

Authors:  Jami E Milam; Venkateshwar G Keshamouni; Sem H Phan; Biao Hu; Srinivasa R Gangireddy; Cory M Hogaboam; Theodore J Standiford; Victor J Thannickal; Raju C Reddy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-12-27       Impact factor: 5.464

10.  Antifibrotic effect by activation of peroxisome proliferator-activated receptor-gamma in corneal fibroblasts.

Authors:  Hongwei Pan; Jiansu Chen; Jintang Xu; Miaojiao Chen; Rong Ma
Journal:  Mol Vis       Date:  2009-11-10       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.